AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Ranitidine (Ranitidine Hydrochloride)
9 registrations across 1 African market— 9 active
Markets with Ranitidine (Ranitidine Hydrochloride)
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Zynatac Tablets# Tablet | 🇳🇬Nigeria | ZMC International Limited | active | Feb 2029 |
| Anytidine Injection Injection | 🇳🇬Nigeria | Amakin Pharmaceuticals Nigeria Limited | active | Oct 2027 |
| Ranitab-150 Tablets Tablet | 🇳🇬Nigeria | La-Lid Pharmaceutical Company Limited | active | Dec 2026 |
| Ranitab-300 Tablets Tablet | 🇳🇬Nigeria | La-Lid Pharmaceutical Company Limited | active | Dec 2026 |
| Sivotac 150 Tablet | 🇳🇬Nigeria | Adpharm Pharmaceutical Industries Limited | active | Aug 2026 |
| Zilatec 150 Tablets# Tablet | 🇳🇬Nigeria | Nisenton Pharmaceuticals Limited | active | Jun 2026 |
| Zilatec 300 Tablets# Tablet | 🇳🇬Nigeria | Nisenton Pharmaceuticals Limited | active | Mar 2026 |
| Zanclotac-150 Tablets# Tablet | 🇳🇬Nigeria | Mayglow Pharmaceutical Limited | active | Dec 2025 |
| Freshborn Ranitidine Tablets Tablet | 🇳🇬Nigeria | Freshborn Industries Ltd | active | Nov 2025 |
Ranitidine (Ranitidine Hydrochloride) in Africa — Regulatory Overview
Ranitidine (Ranitidine Hydrochloride) is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.